| Real-world effectiveness of remdesivir in adults hospitalized with coronavirus disease 2019 (COVID-19): a retrospective, multicenter comparative effectiveness study BT Garibaldi, K Wang, ML Robinson, J Betz, G Caleb Alexander, ... Clinical Infectious Diseases 75 (1), e516-e524, 2022 | 55* | 2022 |
| Patient-reported burden of dry eye disease in the United States: results of an online cross-sectional survey R Dana, J Meunier, JT Markowitz, C Joseph, C Siffel American journal of ophthalmology 216, 7-17, 2020 | 50 | 2020 |
| Use of hydroxychloroquine, remdesivir, and dexamethasone among adults hospitalized with COVID-19 in the United States: a retrospective cohort study HB Mehta, H An, KM Andersen, O Mansour, V Madhira, ES Rashidi, ... Annals of internal medicine 174 (10), 1395-1403, 2021 | 31 | 2021 |
| Patient-reported burden of dry eye disease in the UK: a cross-sectional web-based survey P Hossain, C Siffel, C Joseph, J Meunier, JT Markowitz, R Dana BMJ open 11 (3), e039209, 2021 | 23 | 2021 |
| Burden of dry eye disease in Germany: a retrospective observational study using German claims data C Siffel, N Hennies, C Joseph, V Lascano, P Horvat, M Scheider, ... Acta Ophthalmologica 98 (4), e504-e512, 2020 | 19 | 2020 |
| Direct and indirect costs of infectious conjunctivitis in a commercially insured population in the United States JS Pepose, SP Sarda, WY Cheng, N McCormick, HC Cheung, P Bobbili, ... Clinical Ophthalmology, 377-387, 2020 | 15 | 2020 |
| Statins in kidney transplant recipients: usage, all-cause mortality, and interactions with maintenance immunosuppressive agents S Bae, JYB Ahn, C Joseph, R Whisler, MA Schnitzler, KL Lentine, ... Journal of the American Society of Nephrology 34 (6), 1069-1077, 2023 | 6 | 2023 |
| Incidence of Statin-Associated Adverse Events in Kidney Transplant Recipients S Bae, JB Ahn, C Joseph, R Whisler, MA Schnitzler, KL Lentine, ... Journal of the American Society of Nephrology, 2023 | 2 | 2023 |
| Gabapentin, concomitant prescription of opioids, and benzodiazepines among kidney transplant recipients Y Chen, JYB Ahn, S Bae, C Joseph, M Schnitzler, GP Hess, KL Lentine, ... Clinical Journal of the American Society of Nephrology 18 (1), 91-98, 2023 | 2 | 2023 |
| Alpha-1 antitrypsin deficiency-associated clinical manifestations and healthcare resource use in the United States EM Herrera, C Joseph, ES Brouwer, V Gandhi, M Czorniak COPD: Journal of Chronic Obstructive Pulmonary Disease 18 (3), 315-324, 2021 | 1 | 2021 |
| Estimation of the Prevalence of Genetic and Acquired (non-HIV-associated) Lipodystrophies in the US Using Electronic Medical Record (EMR) Data EA Oral, K Lang, N Campion, P Dhankhar, C Joseph, A Garg DIABETES 64, A438-A439, 2015 | 1 | 2015 |
| Classification of non-hiv lipodystrophy in the us using electronic Medical Record (EMR) Data And Physician Notes E Oral, K Lang, N Campion, P Dhankhar, C Joseph, A Garg Value in Health 18 (3), A278, 2015 | 1 | 2015 |
| Sociodemographic disparities in sodium‐glucose cotransporter‐2 inhibitor use among US kidney transplant recipients: An observational study of real‐world pharmacy records KL Lentine, KN Miyata, NN Lam, C Joseph, M McAdams‐DeMarco, S Bae, ... Clinical Transplantation 38 (4), e15257, 2024 | | 2024 |
| Weighing Risks and Benefits in the Presence of Competing Risks CR Lesko, LC Zalla, J Heyward, C Joseph, JK Edwards Current Epidemiology Reports 10 (4), 221-239, 2023 | | 2023 |
| Thromboprophylaxis in people hospitalized with COVID‐19: Assessing intermediate or standard doses in a retrospective cohort study KM Andersen, CS Joseph, HB Mehta, MB Streiff, JF Betz, RC Bollinger Jr, ... Research and Practice in Thrombosis and Haemostasis 6 (5), e12753, 2022 | | 2022 |
| High-intensity thromboprohylaxis is not associated with reductions in COVID-19 worsening, severe disease, or death C Joseph, KM Andersen, H Mehta, MB Streiff, J Betz, RC Bollinger, ... Pharmacoepidemiology and Drug Safety, 347-347, 2022 | | 2022 |
| Use of hydroxychloroquine, remdesivir, and dexamethasone among adults hospitalized with COVID-19 in the United States: Results from the National COVID Cohort Collaborative (N3C) HB Mehta, HJ An, KM Andersen, O Mansour, V Madhira, ES Rashidi, ... Pharmacoepidemiology and Drug Safety, 27-27, 2021 | | 2021 |
| PRS18 ANALYSIS OF PULMONARY-RELATED CLINICAL MANIFESTATIONS AND HEALTHCARE RESOURCE USE IN PATIENTS IN THE UNITED STATES WITH ALPHA-1 ANTITRYPSIN DEFICIENCY EM Herrera, C Joseph, M Czorniak Value in Health 23, S352, 2020 | | 2020 |
| Pharmacotherapy Treatment Patterns and Antibiotic and Corticosteroid Use in Patients with Severe and Non-Severe Alpha-1 Antitrypsin Deficiency in the United States E Mayen Herrera, C Joseph, M Czorniak C34. CHRONIC AND ACUTE MANAGEMENT AND RESOURCE UTILIZATION FOR COPD, A4823-A4823, 2020 | | 2020 |
| ANALYSIS OF PULMONARY-RELATED CLINICAL MANIFESTATIONS AND HEALTH RESOURCE UTILIZATION IN PATIENTS WITH SEVERE AND NON-SEVERE ALPHA-1 ANTITRYPSIN DEFICIENCY IN THE UNITED STATES EM Herrera, C Joseph, E Brouwer Chest 156 (4), A424, 2019 | | 2019 |
